Format

Send to

Choose Destination
Exp Gerontol. 2016 Dec 15;86:97-105. doi: 10.1016/j.exger.2016.02.013. Epub 2016 Feb 26.

Aging and adipose tissue: potential interventions for diabetes and regenerative medicine.

Author information

1
Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
2
Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA. Electronic address: Kirkland.James@mayo.edu.

Abstract

Adipose tissue dysfunction occurs with aging and has systemic effects, including peripheral insulin resistance, ectopic lipid deposition, and inflammation. Fundamental aging mechanisms, including cellular senescence and progenitor cell dysfunction, occur in adipose tissue with aging and may serve as potential therapeutic targets in age-related disease. In this review, we examine the role of adipose tissue in healthy individuals and explore how aging leads to adipose tissue dysfunction, redistribution, and changes in gene regulation. Adipose tissue plays a central role in longevity, and interventions restricted to adipose tissue may impact lifespan. Conversely, obesity may represent a state of accelerated aging. We discuss the potential therapeutic potential of targeting basic aging mechanisms, including cellular senescence, in adipose tissue, using type II diabetes and regenerative medicine as examples. We make the case that aging should not be neglected in the study of adipose-derived stem cells for regenerative medicine strategies, as elderly patients make up a large portion of individuals in need of such therapies.

KEYWORDS:

Adipose Tissue; Aging; Cellular Senescence; Insulin Resistance; Preadipocyte; Stem Cell

PMID:
26924669
PMCID:
PMC5001933
DOI:
10.1016/j.exger.2016.02.013
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center